Skip to main content

DFCI

Content tagged with DFCI

Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.

Sylvan Baca

Person

Our lab develops and applies computational methods in an emerging space we call “translational epigenomics”. This space encompasses efforts to advance precision oncology by deeply characterizing cancer epigenomes. By examining epigenetic changes in...

William Lotter

Person

The Lotter Lab performs interdisciplinary research with two core aims: 1) developing more robust computer vision algorithms using insights from human vision, and 2) optimizing these algorithms for medical imaging to deliver real-world impact. We aim to...

Cheng-Zhong Zhang

Person

My laboratory studies chromosomal abnormalities in cancer. Examples of such alterations include aneuploidy, whole-genome duplication, and complex chromosomal rearrangements. Despite their prevalence, the origin and functional impact of these alterations...

Eliezer M. Van Allen

Person
To drive precision cancer medicine through clinical computational oncology:
Creating the engine to clinically interpret a patient's cancer genome
Discovering response and resistance mechanisms to cancer therapies through patient-centered molecular profiling...

Kimberly Stegmaier

Person
My research program focuses on the integration of "omic" approaches for the identification of new protein targets and small-molecule modulators of malignancy with an eye toward clinical translation. Cancer discovery efforts in my laboratory have focused...

Chris Sander

Person

The overall goal of our work is to solve biological problems using quantitative methods from bioinformatics, statistical physics, data sciences, statistics, computer science, and mathematics. We apply these computational methods to build predictive...

Matthew Langer Meyerson

Person

We strive to discover genomic and infectious causes for human cancers. We then seek to apply these discoveries to understand mechanisms of cancer pathogenesis, and to improve cancer diagnosis and treatment. A particular focus is lung cancer pathogenesis...

Alexander Gusev

Person
We are quantitative geneticists working on methods to understand complex disease. Our research focuses on deciphering biological mechanisms and trait biology from genome-wide association studies; germline influences of cancer and response to therapy; and...

Todd R. Golub

Person

Todd Golub is a founding core member of the Broad Institute and serves as the institute director.

Golub is a world leader in understanding the basis of cancer, by creating and applying tools of genomics. He has made fundamental discoveries in the...

Rameen Beroukhim

Person

The Beroukhim laboratory focuses on understanding the somatic genetics of cancer, primarily in identifying alterations in chromosomal structure (including copy-number gains and losses and loss of heterozygosity) that contribute to tumor growth, and...